Jul 1, 2009
By:Patrick Clinton
In the long run, pharma wants to sell health, not just drugs.
 |
Jun 1, 2009
By:Patrick Clinton
FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop.
|
May 1, 2009
By:Patrick Clinton
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?
|
Apr 1, 2009
By:Patrick Clinton
Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.
|
Mar 1, 2009
By:Patrick Clinton
The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.
|
Feb 1, 2009
By:Patrick Clinton
No one who cares about global health can be happy with a system that only "eventually" delivers drugs and vaccines for the planet's neediest people
|
Jan 1, 2009
By:Patrick Clinton
It's just the way life works: You're always crossing the bridge before you get to it—or after it's gone
|
Dec 11, 2008
By:Patrick Clinton
Two years ago, an internal Merck survey revealed that its basic research operation was "every flavor of what you don't want." Today the company is in the midst of implementing a new strategy that groups scientists at sites dedicated to particular clinical areas. VP Kathleen Metters explains why - and how.
|
Dec 1, 2008
By:Patrick Clinton
Maybe what you're feeling isn't impending doom. Maybe it's just growing pains.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?